Julie Lemieux

Clinical assistant professor

Laval University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julie Lemieux is a Clinical Assistant Professor at Université Laval in Canada. Her research focuses on breast cancer, specifically areas such as targeted therapy in HER2-positive advanced breast cancer, prognostic factors associated with cannabinoid receptors, and the clinical effectiveness of various treatment modalities. She has published extensively in the field, including studies on metformin's effects in breast cancer trials and factors influencing Oncotype DX 21-Gene Recurrence Scores.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Francine Durocher

Professeure titulaire

Laval University

CANADA

View details

Pamela Goodwin

Professor

University of Toronto

CANADA

View details

Marta Santisteban

Clinica Universidad de Navarra

SPAIN

View details

Bingshu Chen

Professor

Queen's University

CANADA

View details

Josée Savard

Laval University

CANADA

View details

Caroline Diorio

Full Professor

Laval University

CANADA

View details

Karen A. Gelmon

The University of British Columbia

CANADA

View details

Vuk Stambolic

Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie Lemieux

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines.

Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients

Identifying Clinicopathological Factors Associated with Oncotype DX® 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, Canada

Stress-buffering effect of social support on immunity and infectious risk during chemotherapy for breast cancer

Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.

Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.

Collaborators (8)

Francine Durocher

Pamela Goodwin

Marta Santisteban

Bingshu Chen

Josée Savard

Caroline Diorio

Karen A. Gelmon

Vuk Stambolic

Make your next move.